Literature DB >> 12146753

Experimental murine model of disseminated Pseudallescheria infection.

G M González1, R Tijerina, L Najvar, M Rinaldi, I T Yeh, J R Graybill.   

Abstract

Pseudallescheria boydii is found in soil and has a worldwide distribution. This fungus was initially identified as a pathogen targeting a variety of tissues. There are fragmentary data in the literature on the in vitro susceptibility of P. boydii to different antifungal compounds. P. boydii is highly refractory to antifungal treatments. In this study, a murine model of disseminated Pseudallescheria infection was developed to evaluate efficacy of different treatment regimens. A clinical strain of P. boydii was studied in normal and neutropenic outbred ICR mice. Several inocula were tested over a range from 1 x 10(3) to 5 x 10(6) cfu. Groups of eight mice were injected with a intravenous dose of one inoculum. Mortality correlated with the dose of the inoculum, and with immunosuppression. Quantitative cultures of various tissues showed initial dissemination of disease in immune competent mice. This was followed by, reduction of tissue burden, except in the brain. In contrast, disseminated infection persisted in most organs in immunosuppressed animals (p < 0.0001). This model should be appropriate for in vivo evaluation of antifungal chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12146753     DOI: 10.1080/mmy.40.3.243.248

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  6 in total

1.  Disruption of the Aspergillus fumigatus gene encoding nucleolar protein CgrA impairs thermotolerant growth and reduces virulence.

Authors:  Ruchi Bhabhra; Michael D Miley; Eleftherios Mylonakis; Doug Boettner; Jarrod Fortwendel; John C Panepinto; Michael Postow; Judith C Rhodes; David S Askew
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

2.  Development and validation of a quantitative PCR assay for diagnosis of scedosporiosis.

Authors:  Maria V Castelli; Maria J Buitrago; Leticia Bernal-Martinez; Alicia Gomez-Lopez; Juan L Rodriguez-Tudela; Manuel Cuenca-Estrella
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

3.  Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice.

Authors:  Javier Capilla; Carolina Serena; F Javier Pastor; Montserrat Ortoneda; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

4.  Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays.

Authors:  Gloria M González; Rolando Tijerina; Laura K Najvar; Rosie Bocanegra; Michael G Rinaldi; David Loebenberg; John R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

5.  Pharmacodynamics of Voriconazole for Invasive Pulmonary Scedosporiosis.

Authors:  Helen Box; Clara Negri; Joanne Livermore; Sarah Whalley; Adam Johnson; Laura McEntee; Ana Alastruey-Izquierdo; Jacques F Meis; Christopher Thornton; William Hope
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

Review 6.  Mycetoma medical therapy.

Authors:  Oliverio Welsh; Hail Mater Al-Abdely; Mario Cesar Salinas-Carmona; Ahmed Hassan Fahal
Journal:  PLoS Negl Trop Dis       Date:  2014-10-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.